We found 114 records for "Legal"

Articles

How multinational pharmaceutical companies deal with bribery and corruption risks in China

25th June 2014

 How multinational pharmaceutical companies deal with bribery and corruption risks in ChinaArticles

Recent investigations by Chinese authorities into bribery and corruption allegations in multinational pharmaceutical companies in China show an increased commitment to crack down on corruption.Since 2009, China has accelerated its...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

TTIP matters for patients and the global economy alike

29th April 2014

 TTIP matters for patients and the global economy alikeArticles

Andrew Hotchkiss, President of Europe, Canada & Australia at Eli Lilly and Company, explores how the Transatlantic Trade and Investment Partnership (TTIP) can benefit the patients of tomorrow.Albert Einstein, one...

Read more

Pharma products, patents & problems – the Unified Patent Court: plan your patent strategy

24th April 2014

 Pharma products, patents & problems – the Unified Patent Court: plan your patent strategyArticles

As we see the patent system in Europe undergo its biggest overhaul in decades, we explore the new Unified Patent Court Agreement and how it will impact on your patent...

Read more

News

GSK China guilty of bribery

19th September 2014

 GSK China guilty of briberyNews

The Changsha Intermediate People's Court in Hunan Province, China, has ruled that GlaxoSmithKline China Investment Co. Ltd (GSKCI) has, according to Chinese law, offered money or property to non-government personnel...

Read more

BMS sues Merck over cancer immunotherapy patent

8th September 2014

 BMS sues Merck over cancer immunotherapy patentNews

The battle for supremacy in the field of anti-PD-1 cancer immunotherapy has just intensified, with Bristol Myers Squibb suing rivals Merck over an alleged patent infringement.BMS was the first company...

Read more

Senator to table anti-tax inversion bill this week

8th September 2014

 Senator to table anti-tax inversion bill this weekNews

US Senator Chuck Schumer is determined to close the loophole that is allowing corporations to keep assets out of reach of the US taxman, and aims to claw back money...

Read more

US lawmakers aim to block tax inversion deals

16th July 2014

 US lawmakers aim to block tax inversion dealsNews

US companies could be blocked from reducing their corporate tax liabilities by merging with overseas companies - a process known as tax inversion - if President Obama has his way.The...

Read more

Events

Payers' Forum Europe

1st October 2014 - 2nd October 2014

Payers' Forum Europe

This is the event to ensure your product’s access and to ensure its reimbursed and at the best price. Speaking at the event, we have the top payers from NHS,...

Read more

The 2nd Microbiome/Microbiome R&D and Business Collaboration Forum

2nd October 2014 - 3rd October 2014

The 2nd Microbiome/Microbiome R&D and Business Collaboration Forum

Research into the Microbiome is having an impact on our understanding of a whole host of medical conditions. From arthritis to cancer, diabetes to obesity and organ development to metal...

Read more

2nd International Congress on Paragraph IV Litigation Strategy

29th October 2014 - 30th October 2014

2nd International Congress on Paragraph IV Litigation Strategy

Successful IP Litigation Strategies for Brand Name and Generic Manufacturers Imminent blockbuster patent expiration…new regulatory hurdles and procedural requirements created by the Biologics Price Competition and Innovation and America Invents Act…constantly...

Read more

Big Data & Analytics for Pharma Summit

5th November 2014 - 6th November 2014

Big Data & Analytics for Pharma Summit

The Big Data & Analytics for Pharma Summit returns to Philadelphia on November 5 & 6, boasting a lineup of the most influential pharmaceutical executives driving big data initiatives in...

Read more